Old vaccines and new vaccines explained

I am a strict constructionist on the necessity of vaccines. Since Edward Jenner produced a vaccine for smallpox in 1799, millions, perhaps billions of lives have been saved by vaccines. The search for new vaccines will never end because infectious organisms constantly evolve. Influenza viruses evolve to escape last year’s immune defenses. We have yet to master HIV with a vaccine. 

From the time of Edward Jenner, there has been resistance to vaccination.  Resistance to measles vaccine is currently high. I do not know the reason for this rejection of vaccines. Some people believe that the diseases we vaccinate against are not so bad. Others think that good parenting will protect their kids, or some vaccines are more dangerous than the disease they are designed to prevent, or worse, that the vaccines cause the disease. Some people are infuriated that government, through public health authorities, has control over their families. Some people feel that scientists and physicians condescend to them, which nobody likes.

Let me explain how to make a vaccine and show that it works. The first thing we must do with any infectious disease, whether Ebola, measles or anthrax, is to identify and purify a virus or bacteria that causes the disease under question. The rules for establishing this connection were worked out by the German bacteriologist Robert Koch in the 1880s. 

 

The second, third, and fourth vaccines came 80 years after Jenner’s smallpox vaccine (this 80 years contains multitudes.) They were to counter chicken cholera, anthrax, and rabies — rabies being the first treatment of a feared human disease. Louis Pasteur and his students grew these pathological organisms, realized that they could weaken them, that the weakened forms could still provoke resistance, and that the animals or humans (in the case of rabies) would be protected against future infection. 

They knew nothing about the immune system — only that they could make animals resistant. It was neither simple nor safe to make and test these vaccines, but in doing it, they worked out the principles of microbiology that have been the foundation for infectious disease research ever since. They faced strong opposition, but Pasteur was a warrior and defended his new science fiercely.     

There followed, by the 1930s, vaccines to diphtheria, tetanus and whooping cough that were gradually administered across Europe and the United States with reductions in these diseases. In the 1950s, the polio vaccines (Salk and Sabin) became available and then in 1963, measles, followed by mumps and rubella. These are the familiar DPT and MMR vaccines.   

 

Let’s concentrate on measles. In 1963, there were about 500,000 cases of measles in American children. Almost every child got infected, but the virus was not (and is not) benign. Some infections led to complications, mostly encephalitis, and there were about 400 deaths. 

In 1963, a measles vaccine was developed and in a few years the disease disappeared in the United States and other countries, with only sporadic cases.  Now, with refusal to take the vaccine, hundreds of cases have appeared. According to the Centers for Disease Control, there were 880 cases from Jan. 1 to May 17 this year in the U.S., a large increase from 2018 when there were 372. Almost none of these patients had been vaccinated. 

The MMR vaccine also provides resistance to mumps and Rubella, and predictably, new cases have appeared. Mumps has its own set of complications, including sterility. Rubella causes birth defects. MMR does not cause autism, though that remains a fear among some parents. 

The pediatrician and infectious disease physician Paul Offit has made the point that a dreadful epidemic might convince people to vaccinate, but until then there may be little change. Still, it would be a shame to ignore evidence for the efficacy of the 20 vaccines we now give to children.

Could such a major epidemic erupt? Influenza or other respiratory virus is always a possibility. The H1N1 flu pandemic of 2009-2010 mercifully collapsed, unlike that of 1918-1919, which killed about 50 million people worldwide. For sheer terror consider the case of Ebola, which this column has covered extensively. (Go to www.tricornernews.com or and search for Richard Kessin Ebola.)

Two-thirds of Ebola victims die. We now have what appears to be an effective vaccine. For various reasons there is unlikely to be a large outbreak of Ebola in the United States, but if there were, my guess is that as Dr. Offit suggested, a lot of minds would change. 

Richard Kessin, PhD, is professor emeritus of pathology and cell biology at The Columbia University Irving Medical Center.  If you have a group that would like further explanations of infection and immunity or other biological subjects, he would be happy to come talk with you. Email him at Richard.Kessin@gmail.com.

 

 

 

 

 

Latest News

To mow or not to mow?

To mow or not to mow?

A partially mowed meadow in early spring provides habitat for wildlife while helping to keep invasive plants in check.

Dee Salomon

Love it or hate it, there is no denying the several blankets of snow this winter were beautiful, especially as they visually muffled some of the damage they caused in the first place.There appears to be tree damage — some minor and some major — in many places, and now that we can move around, the pre-spring cleanup begins. Here, a heavy snow buildup on our sun porch roof crashed onto the shrubs below, snapping off branches and cleaving a boxwood in half, flattening it.

The other area that has been flattened by the snow is the meadow, now heading into its fourth year of post-lawn alterations. A short recap on its genesis: I simply stopped mowing a half-acre of lawn, planted some flowering plants, spread little bluestem seeds and, far less simply, obsessively pluck out invasive plants such as sheep sorrel and stilt grass. And while it’s not exactly enchanting, it is flourishing, so much so that I cannot bring myself to mow.

Keep ReadingShow less

Where the mat meets the market

Where the mat meets the market

Kathy Reisfeld

Elena Spellman

In a barn on Maple Avenue in Great Barrington, Kathy Reisfeld merges two unlikely worlds: wealth management and yoga, teaching clients and students alike how stability — financial and emotional — comes from practice.

Her life sits at an intersection many assume can’t exist: high finance and yoga. One world is often reduced to greed, the other to “woo-woo” stretching. Yet in conversation, she makes both feel grounded, less like opposites and more like two languages describing the same human need for stability.

Keep ReadingShow less
Capitol hosts first-ever staging of Civil War love story

Playwright Cinzi Lavin, left, poses with Kathleen Kelly, director of ‘A Goodnight Kiss.’

Jack Sheedy

Litchfield County playwright Cinzi Lavin’s “A Goodnight Kiss,” based on letters exchanged between a Civil War soldier and the woman who became his wife, premiered in 2025 to sold-out audiences in Goshen, where the couple once lived. Now the original cast, directed by Goshen resident Kathleen Kelly, will present the play beneath the gold dome of Connecticut’s Capitol in Hartford as part of the state’s America250 commemoration — marking what organizers believe may be the first such performance at the Capitol.

“I don’t believe any live performances of an actual play (at the Capitol) have happened,” said Elizabeth Conroy, administrative assistant at the Office of Legislative Management, who coordinates Capitol events.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Hunt Library launches VideoWall for filmmakers

Yonah Sadeh, Falls Village filmmaker and curator of David M. Hunt Library’s new VideoWall.

Robin Roraback

The David M. Hunt Library in Falls Village, known for promoting local artists with its ArtWall, is debuting a new feature showcasing filmmakers. The VideoWall will premiere Saturday, March 28, at 6 p.m. with a screening of two short films by Brooklyn-based documentary filmmaker and animator Imogen Pranger.

The VideoWall is the idea of Falls Village filmmaker Yonah Sadeh, who also serves as curator. “I would love the VideoWall to become a place that showcases the work of local filmmakers, and I hope that other creatives in the area will submit their work to be shown,” he said.

Keep ReadingShow less

A bowl full of stars

A bowl full of stars

A bowl full of stones.

Cheryl Heller

There’s a bowl in my studio where pieces of the planet reside. I bring them home from travels, picking them up not for their beauty or distinction but for their provenance. I choose the ones that speak to me — the ones next to pyramids, along hiking trails, on city sidewalks or volcanic slopes.

I like how stones feel in my hand: weighty, grounding. I don’t mind them making my pockets and suitcase heavier. The bowl is about the size of an average carry-on. It has been years since it was light enough for me to lift.

Keep ReadingShow less
One-woman show brings Mumbet’s fight for freedom to Scoville Library
One-woman show brings Mumbet’s fight for freedom to Scoville Library
One-woman show brings Mumbet’s fight for freedom to Scoville Library

On March 29, writer, producer and director Tammy Denease will embody the life and story of Elizabeth Freeman, widely known as Mumbet, in two performances at the Scoville Library in Salisbury. Presented by Scoville Library and the Salisbury Association Historical Society, the performance is part of Salisbury READS, a community-wide engagement with literature and civic dialogue.

Mumbet was the first enslaved woman in Massachusetts to sue successfully for her freedom in 1781. Her victory helped lay the legal groundwork for the abolition of slavery in the state just two years later. In bringing Mumbet’s story to life, Denease does more than reenact history.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.